Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-12-22A Phase 1/2 Dose Escalation Study With Expansion Cohorts to Investigate the Safety, Biologic and Anti-tumor Activity of ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
-
CLINICAL_TRIALS study record update · 2022-12-21A Phase I Dose Finding Study of Oral LXH254 in Adult Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations
-
CLINICAL_TRIALS study record update · 2022-12-15A Randomized Multicenter Phase II Trial to Evaluate the Safety, Efficacy and Immunogenicity of Vaccination With Folate Receptor Alpha Peptides With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer and a Response or Stable Disease to Platinum Therapy
-
CLINICAL_TRIALS study record update · 2022-12-13Intermittent Fasting Accompanying Chemotherapy in Gynecological Cancers - a Randomized, Controlled, Two-armed Intervention Study
-
CLINICAL_TRIALS study record update · 2022-12-07Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-12-07An Open-label, Phase II Clinical Trial of of a Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Adverse Reactions Nausea of Niraparib in in the First-line Maintenance Treatment in Advanced Epithelial Ovarian Cancer (EOC) Patients
-
CLINICAL_TRIALS study record update · 2022-11-23Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation Using Antithymocyte Globulin With Either Melphalan and Cladribine or Total Lymphoid Irradiation
-
CLINICAL_TRIALS study record update · 2022-11-17A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin in Patients With Advanced-stage Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2022-11-07A Phase I Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma
-
CLINICAL_TRIALS study record update · 2022-11-02A Pilot Study of Heated Intraperitoneal Chemotherapy (HIPEC) After Interval Cytoreductive Surgery (CRS) in Patients Who Have Received Neoadjuvant Chemotherapy (NACT) for Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancers
-
CLINICAL_TRIALS study record update · 2022-10-28A Single Arm, Exploratory, Multicenter Clinical Study of Fluzopari Combined With Apatinib Neoadjuvant Therapy in Patients With Advanced Non R0 Resectable Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2022-10-20Thiol-disulfide Homeostasis in Patients With Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2022-10-18The Efficacy and Adverse Effects of Niraparib in Ovarian Cancer: a Prospective Real-world Product Registration Study.
-
CLINICAL_TRIALS study record update · 2022-10-14Decision Making Interventions for Women Receiving Uninformative BRCA1/2 Test Results or Positive BRCA1/2 Test Results
-
CLINICAL_TRIALS study record update · 2022-10-14SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care
-
CLINICAL_TRIALS study record update · 2022-10-04Role of Laparoscopy in Assessing Tumor Resectability in Ovarian Cancer Cases
-
CLINICAL_TRIALS study record update · 2022-09-27International Phase III Randomised Study to Evaluate the Efficacy of Maintenance Therapy With Olaparib and Cediranib or Olaparib Alone in Patients With Relapsed Ovarian Cancer Following a Response to Platinum-based Chemotherapy
-
CLINICAL_TRIALS study record update · 2022-09-26Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy
-
CLINICAL_TRIALS study record update · 2022-09-23Phase-II Study of Olaparib as Maintenance Therapy After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma
-
CLINICAL_TRIALS study record update · 2022-09-23Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma
-
CLINICAL_TRIALS study record update · 2022-09-22A Prospective, Single-arm, Multicenter Phase Ⅱ Clinical Study of Fluzoparib Combined With Bevacizumab in Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With PARPi
-
CLINICAL_TRIALS study record update · 2022-09-21Evaluation of the Immunogenicity of Vaccination With Synthetic Peptides in Adjuvant in Patients With Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
-
CLINICAL_TRIALS study record update · 2022-09-13Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.
-
CLINICAL_TRIALS study record update · 2022-09-10A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) In BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, and High Grade Serous Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2022-09-10An Open-label Phase II Study of Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy - RESOUND